GI & Endoscopy

Takeda Pharmaceutical Co. is exploring a deal to sell several of its over-the-counter and prescription drugs in emerging markets and Western Europe, The Japan Times reports.

Summit, N.J.-based pediatric gastroenterologist Michael Tyshkov, MD, was formally indicted on six counts of sexual assault-related offenses by a Union County, N.J.-based grand jury, Tap Into Westfield reports.

A class-action lawsuit alleging the American Board of Internal Medicine performed monopolistic actions related to its maintenance-of-certification exams was dismissed Sept. 26. 

Miguel Saps, MD, is chief of the division of pediatric gastroenterology, hepatology and nutrition at the University of Miami Health System.

Exact Sciences' week started with a boom when the FDA expanded its approval for the company's noninvasive colon cancer test Cologuard to include the 45 to 49 age range. 

The FDA cleared six new Fujifilm Medical Systems, U.S.A. endoscopic products.

Gastroenterology-focused pharmaceutical company Phantom Pharmaceuticals will appoint Terrie Curran as CEO after Celgene Corp. is acquired by Bristol-Myers Squibb.

NBC affiliate 4 New York's investigative team found patient files for Jonathan Warman, MD, and Alexander Chun, MD, outside with the trash.

Takeda and Evotec SE entered into a multiyear partnership to develop new drug therapies.

Here are eight updates from gastroenterology companies and practices from the past week: